University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
|
+$10.2M |
| 2 |
Beam Therapeutics
BEAM
|
+$2.36M |
| 3 |
Deere & Co
DE
|
+$24.4K |
| 4 |
Hess Midstream
HESM
|
+$9.9K |
| 5 |
Broadridge
BR
|
+$6.44K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$5.88M |
| 2 |
HCP
HashiCorp, Inc. Class A Common Stock
HCP
|
+$5.52M |
| 3 |
Select Water Solutions
WTTR
|
+$4.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$335K |
| 5 |
Home Depot
HD
|
+$316K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.25% |
| 2 | Healthcare | 2.74% |
| 3 | Industrials | 0.01% |
| 4 | Energy | 0% |
| 5 | Utilities | 0% |
Similar funds
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q1 2023 Portfolio in Review
As of Q1 2023, University of Texas/Texas AM Investment Management Co (UTIMCO) held 56 positions worth $260M, down 2% from $266M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
University of Texas/Texas AM Investment Management Co (UTIMCO) withdrew a net $8.14M in Q1 2023, closing 37 positions and reducing 3 holdings. Its most notable exit was Karuna Therapeutics, Inc. Common Stock, an estimated $5.88M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 5% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Beam Therapeutics worth $1.83M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q1 2023 buy was Beam Therapeutics: 59,839 shares worth $1.83M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) added most to JPMorgan BetaBuilders MSCI US REIT ETF in Q1 2023, an estimated $10.2M increase.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q1 2023 reduction was HashiCorp, Inc. Class A Common Stock, cutting an estimated $5.52M.
- University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2023, selling an estimated $5.88M.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 100% of its $260M portfolio in Q1 2023.
- University of Texas/Texas AM Investment Management Co (UTIMCO) opened 4 new positions and closed 37 in Q1 2023.
- University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 2% quarter-over-quarter to $260M.
Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2023, filed 22 May 2023.